Literature DB >> 18247078

The significance of platelet activation in ankylosing spondylitis.

Feng Wang1, Chun-Gen Yan, Hai-Yan Xiang, Tao Xing, Nian-Song Wang.   

Abstract

The objective of this study was to explore the significance of platelet activation in patients with ankylosing spondylitis (AS). Thirty-five AS patients and 15 normal controls were selected from November 2005 to October 2006. The number of CD62P- and CD63-positive cells were detected by flow cytometry. At the same time, the erythrocyte sedimentation rate (ESR), platelet count (PLT) and C-reactive protein (CRP) were determined in both groups. The percentage of CD62P-positive cell in AS patients (13.60 +/- 7.64%) was significantly higher than that in control group (2.78 +/- 1.04%; P < 0.01). The percentage of CD63-positive cell in AS patients (6.92 +/- 4.16%) was significantly higher than that in control group (4.13 +/- 1.85%; P < 0.05). The levels of CRP (20.18 +/- 23.17 mg/l), PLT (259.54 +/- 102.59 x 10(9)/l) and ESR (36.86 +/- 31.23 mm/h) in AS patients were higher than those in normal controls, respectively (3.21 +/- 2.18 mg/l, P < 0.01; 197.00 +/- 55.70 x 10(9)/l, P < 0.01; 12.25 +/- 5.05 mm/h, P < 0.05). Platelet activation may be a sign of AS exacerbation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18247078     DOI: 10.1007/s10067-008-0847-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  7 in total

Review 1.  New discoveries with mice mutant in endothelial and platelet selectins.

Authors:  D W Hartwell; D D Wagner
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

2.  Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface.

Authors:  Olga D Genbacev; Akraporn Prakobphol; Russell A Foulk; Ana R Krtolica; Dusko Ilic; Mark S Singer; Zhi-Qiang Yang; Laura L Kiessling; Steven D Rosen; Susan J Fisher
Journal:  Science       Date:  2003-01-17       Impact factor: 47.728

3.  Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1.

Authors:  Gunther G Pendl; Caroline Robert; Meike Steinert; Renate Thanos; Ruth Eytner; Eric Borges; Martin K Wild; John B Lowe; Robert C Fuhlbrigge; Thomas S Kupper; Dietmar Vestweber; Stephan Grabbe
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

Review 4.  Insights into selectin function from knockout mice.

Authors:  P S Frenette; D D Wagner
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

Review 5.  Remission in ankylosing spondylitis.

Authors:  J Zochling; J Braun
Journal:  Clin Exp Rheumatol       Date:  2006 Nov-Dec       Impact factor: 4.473

6.  Heparan sulfate-like proteoglycans mediate adhesion of human malignant melanoma A375 cells to P-selectin under flow.

Authors:  Y Q Ma; J G Geng
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

7.  Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins.

Authors:  P S Frenette; T N Mayadas; H Rayburn; R O Hynes; D D Wagner
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

  7 in total
  10 in total

1.  The vasoactive intestinal polypeptide (VIP) levels at the patients with ankylosing spondylitis and its association with inflammation markers.

Authors:  Selim Nalbant; Eylem Cagiltay; Burak Sahan; Hakan M Terekeci; Cagatay Oktenli
Journal:  Rheumatol Int       Date:  2010-03-26       Impact factor: 2.631

2.  Does anti-TNF therapy cause any change in platelet activation in ankylosing spondylitis patients? A comparative study.

Authors:  Hüseyin Orüm; Gülsüm Emel Pamuk; Omer Nuri Pamuk; Muzaffer Demir; Burhan Turgut
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

3.  Global Proteomic Analyses Reveals Abnormal Immune Regulation in Patients With New Onset Ankylosing Spondylitis.

Authors:  Zongchao Yu; Xiaoping Hong; Xiaoli Zhang; Fengping Zheng; Fanna Liu; Huixuan Xu; Chengxin Zhu; Wanxia Cai; Dongzhou Liu; Lianghong Yin; Bo Hu; Donge Tang; Yong Dai
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

4.  Modulation of platelet-derived microparticles to adhesion and motility of human rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  Wenwen Wang; Jiahuan Liu; Binzhou Yang; Zhongshuang Ma; Guiping Liu; Weigan Shen; Yu Zhang
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

5.  Associations of Platelet Count with Inflammation and Response to Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis.

Authors:  Hongyan Qian; Rongjuan Chen; Bin Wang; Xiaoqing Yuan; Shiju Chen; Yuan Liu; Guixiu Shi
Journal:  Front Pharmacol       Date:  2020-11-06       Impact factor: 5.810

6.  Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis.

Authors:  Junlai Wu; Lifang Yan; Kexia Chai
Journal:  J Clin Lab Anal       Date:  2021-08-21       Impact factor: 2.352

7.  Risk factors of uveitis in ankylosing spondylitis: An observational study.

Authors:  Li Sun; Rui Wu; Qin Xue; Feng Wang; Peirong Lu
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Single-stage anterior debridement and reconstruction with tantalum mesh cage for complicated infectious spondylitis.

Authors:  Shih-Chieh Yang; Hung-Shu Chen; Yu-Hsien Kao; Yuan-Kun Tu
Journal:  World J Orthop       Date:  2017-09-18

9.  Expression and clinical significance of circular RNA hsa_circ_0079787 in the peripheral blood of patients with axial spondyloarthritis.

Authors:  Qing Luo; Biqi Fu; Lu Zhang; Yang Guo; Zikun Huang; Junming Li
Journal:  Mol Med Rep       Date:  2020-09-17       Impact factor: 2.952

10.  RAB5C, SYNJ1, and RNF19B promote male ankylosing spondylitis by regulating immune cell infiltration.

Authors:  Di Zhang; Bo Li; Rui Guo; Jionglin Wu; Canchun Yang; Xu Jiang; Chi Zhang; Haolin Yan; Qiancheng Zhao; Zheyu Wang; Qiwei Wang; Renyuan Huang; Zhilei Zhang; Xumin Hu; Liangbin Gao
Journal:  Ann Transl Med       Date:  2021-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.